πŸ‡ΊπŸ‡Έ FDA

Intelligence Β· Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors β€” phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text β€” searchable for business development and competitive intelligence.

1,328 results for β€œChina” Clear

  1. ThisCART19A

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Autoimmune Hemolytic Anemia

    phase 1 mab active

    1 trial

  2. ThisCART7 cells

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    T-Acute Lymphoblastic Leukemia

    phase 1 mab active

    1 trial

  3. Tofacitinib tablets

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Amyotrophic Lateral Sclerosis

    phase 1 small molecule active

    1 trial

  4. Tranexamic AcidοΌ›

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Iatrogenic Endobronchial Bleeding

    phase 1 small molecule active

    1 trial

  5. UB-221

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Chronic Spontaneous Urticaria

    phase 1 mab active

    1 trial

  6. UCBMC

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Stroke

    phase 1 mab active

    1 trial

  7. UCMSC

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Bronchopleural Fistula

    phase 1 mab active

    1 trial

  8. UX-GIP001

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Epilepsy

    phase 1 small molecule active

    1 trial

  9. VGB-R04

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Hemophilia B

    phase 1 gene therapy active

    1 trial

  10. Vemurafenib Oral Tablet [Zelboraf]

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    BRAF V600E-mutated /MSS Metastatic Colorectal Cancer

    phase 1 small molecule active

    1 trial

  11. Vitamin B6-restricted diet + immunotherapy

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Solid Tumor Cancer

    phase 1 other active

    1 trial

  12. WGc-0201 injection

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Hepatocellular Carcinoma (HCC)

    phase 1 mab active

    1 trial

  13. WPQW granule

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Non-erosive Reflux Disease

    phase 1 small molecule active

    1 trial

  14. WSK-IM05 (4Γ—10^10 vp)

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    HPV-positive Oropharyngeal Squamous Cell Carcinoma

    phase 1 mab active

    1 trial

  15. YM178

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Healthy Chinese Volunteers

    phase 1 small molecule completed

    1 trial

  16. YMN-A02 100ΞΌg

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Hepatocellular Carcinoma

    phase 1 mab active

    1 trial

  17. YMN101

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Malignant Tumor

    phase 1 mab active

    1 trial

  18. YTS104 Cells injection

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Relapsed or Refractory Multiple Myeloma

    phase 1 mab active

    1 trial

  19. YTS109 cell

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Autoimmune Hemolytic Anemia

    phase 1 small molecule active

    1 trial

  20. YTS109 cell

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Systemic Lupus Erythematosus (SLE)

    phase 1 mab active

    4 trials

  21. YTS109 cell

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Systemic Lupus Erythematosus

    phase 1 small molecule active

    1 trial

  22. YTS109 cell injection

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Lupus Nephritis (LN)

    phase 1 small molecule active

    1 trial

  23. Yang Yin Fu Zheng Jie Du therapy

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Hepatocellular Carcinoma

    phase 1 small molecule completed

    1 trial

  24. Yinhu Qingwen Granules

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Viral Pneumonia

    phase 1 small molecule active

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync β€” verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources